OptiGen, LLC
OptiGen is happy to share the following information
regarding Poodles tested for PRA during
the 4th quarter of 2006 (10/1/06-12/27/06):

Total Poodles tested - 346
Normal/Clear - 240
Carrier - 98
Affected - 8

Total Toy Poodles tested - 196
Normal/Clear - 130
Carrier - 60
Affected - 6

Total Miniature Poodles tested - 150
Normal/Clear - 110
Carrier - 38
Affected - 2

Countries testing this period include - US, UK,
Estonia, Lithuania, Russia, Italy, Sweden, Denmark,
Germany, Canada, Israel, Poland, the Netherlands,
Norway, France, and Switzerland.

If you have any questions, please feel free to
email me.
Sincerely,
Becky Iddings
Administrative Support Associate
**********************************************
OptiGen, LLC
Cornell Business & Technology Park
767 Warren Road, Suite 300
Ithaca, NY 14850
phone: 607-257-0301
fax: 607-257-0353
email: genetest@optigen.com
web: www.optigen.com

AllaF добавил(а) [date]1168569726[/date]:
Distributors of OptiGen® Genetic Tests

OptiGen holds exclusive licenses to several patented and patent-pending canine genetic tests, as listed below. From time-to-time, another group claims to offer OptiGen tests without permission or appropriate licensing. This summary list will help you identify legitimate providers so that you can obtain the highest quality and most reliable long-term services available.

Australia/New Zealand/ Japan and several Asia Pacific countries:
Genetic Science Services (www.gtg.com.au) is licensed by OptiGen to be the exclusive provider of prcd-PRA tests and the CEA tests (among other tests) in these regions. In a corollary agreement with GTG, OptiGen agreed to not accept any samples from this territory for any of the tests it offered as of May 2006.

Europe :
No license has been issued to any European company for OptiGen® exclusive tests, in particular the prcd-PRA tests and the CEA tests for all relevant breeds.

Two companies in Europe are approved to act as OptiGen’s agents by receiving blood samples, extracting DNA, and shipping the DNA to OptiGen for testing in the OptiGen labs. These companies are VHL in The Netherlands (www.vhlgenetics.com) and Antagene in France (www.antagene.com).

United States and Canada :
No license has been issued to any other company for the OptiGen® exclusive tests and no other company serves as agent for sample shipments. Access to testing directly through OptiGen is easiest done online at this website.

All other locations:
There are no other distributor or agent relationships at present. OptiGen works directly with breeders worldwide to assist with sample shipments and testing.


Patents and Licenses:

OptiGen holds the exclusive license for these tests from Cornell Research Foundation, Inc.:
CEA/CH Patent Pending, International
CSNB Patent No. 6,201,114
prcd-PRA US Patent No. 5,804,388
prcd-PRA Canadian Patent No. CA2306194
prcd-PRA U.K. Patent No. 2 341 926
prcd-PRA Mutation Patent Pending, International
prcd-PRA LD Patent Pending, International

OptiGen holds the exclusive license for U.S. and Canada and a non-exclusive license for other regions from the inventors at U. of New South Wales and the Border Collie Club of NSW, Australia , for this test:
NCL Patent Pending, International

OptiGen holds the exclusive U.S. license for this test from the inventors at the Swedish University in Uppsala , Sweden :
CLAD Patent No. 6,210,897

OptiGen holds the exclusive U.S. license for this test from Stanford University School of Medicine:
NARC Patent Pending

OptiGen holds the exclusive U.S. and Canada license for this test from Merlogen, LLC:
FN Patent Pending

OptiGen tests are provided pursuant to a license from Genetic Technologies Limited for their Non-Coding/Mapping Patents.